Opportunity Information: Apply for PAR 18 594
The NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required), funding opportunity number PAR-18-594, is a National Institutes of Health (NIH) discretionary grant mechanism designed to support the actual conduct and implementation of investigator-initiated interventional clinical trials across all phases. In practical terms, this FOA is aimed at studies that are ready to enroll participants and carry out an intervention (for example, testing a drug, biologic, device, procedure, or behavioral intervention) and that directly align with the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) mission areas. NIAMS signals that it is looking for trials that are hypothesis-driven, structured around clear, measurable milestones, and positioned to make a meaningful impact in NIAMS-relevant clinical research.
A key feature of this opportunity is the typical two-part pathway NIAMS expects for clinical trials. Most applicants are generally expected to complete an R34 planning phase first (Part 1), then apply for the U01 implementation award (Part 2). The R34 is commonly used to finish essential pre-trial work such as finalizing the protocol and manual of operations, confirming feasibility and recruitment approaches, solidifying the statistical analysis plan, setting up data management and quality control systems, ensuring regulatory readiness (for example, IRB processes), and generally demonstrating that the trial is executable. At the same time, NIAMS allows flexibility: if a team has already completed all necessary planning and preparation through other funding or established infrastructure, they may apply directly to the U01 without having previously held an R34. The overall message is that NIAMS wants implementation-ready projects, whether the readiness was achieved through the NIAMS planning route or through other credible means.
Because this is a cooperative agreement (U01) rather than a standard research project grant, awardees should expect substantial NIH involvement consistent with the cooperative model. While the investigators retain primary responsibility for designing and running the trial, the NIH (through NIAMS program staff) typically has an active partnership role that can include coordination around agreed-upon milestones, oversight of progress, and other collaborative activities that help ensure the trial stays on track. The FOA explicitly emphasizes milestone-defined trials, which usually means applicants need to propose concrete performance and timeline targets (for example, site activation, recruitment rates, retention targets, data quality indicators, and interim deliverables) and be prepared for continued monitoring against those targets during the award period.
Eligibility is broad and includes many types of domestic organizations and governmental entities. Eligible applicants listed include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; public housing authorities/Indian housing authorities; Native American tribal organizations other than federally recognized tribal governments; nonprofits (both 501(c)(3) and non-501(c)(3), excluding higher education institutions when categorized separately); for-profit organizations other than small businesses; and small businesses. The FOA also highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, tribal governments that are not federally recognized, and U.S. territories or possessions. However, it is explicit that non-domestic (non-U.S.) entities (foreign institutions/organizations) are not eligible to apply as the applicant organization, and non-domestic components of U.S. organizations are also not eligible to apply. At the same time, foreign components (as defined in the NIH Grants Policy Statement) are allowed, meaning a U.S. applicant organization may include certain foreign collaborations or performance sites if they meet NIH policy definitions and requirements.
From an administrative perspective, the sponsoring agency is the National Institutes of Health, the activity category is Health, and the CFDA number associated with this opportunity is 93.846. The FOA record provided lists an original closing date of 2020-11-03 and a creation date of 2018-01-26. The provided source data does not specify an award ceiling or the expected number of awards, so applicants would normally need to consult the full FOA text and NIAMS guidance for budget expectations, project period norms, and any Institute-specific caps or constraints. Overall, the opportunity is best understood as NIAMS support for well-prepared, high-impact, interventional clinical trials that are ready to move from planning into execution, with a cooperative structure and clear accountability through milestones.Apply for PAR 18 594
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846.
- This funding opportunity was created on 2018-01-26.
- Applicants must submit their applications by 2020-11-03. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
FAQs: NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) - PAR-18-594
What is this funding opportunity?
This opportunity is the NIAMS Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required), funding opportunity number PAR-18-594. It is an NIH discretionary grant mechanism intended to support the conduct and implementation of investigator-initiated interventional clinical trials across all phases, as long as they align with NIAMS mission areas.
Who is the sponsoring agency?
The sponsoring agency is the National Institutes of Health (NIH), through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
What type of grant mechanism is this?
This is a cooperative agreement (U01), not a standard research project grant. Under the cooperative model, NIH/NIAMS program staff typically have an active partnership role while the investigators retain primary responsibility for the trial.
Are clinical trials required under this FOA?
Yes. The FOA is labeled "U01 Clinical Trial Required" and is designed specifically to support interventional clinical trials that are ready to be implemented.
What kinds of studies are supported?
The FOA supports investigator-initiated interventional clinical trials across all phases that are ready to enroll participants and implement an intervention. Examples of interventions mentioned include a drug, biologic, device, procedure, or behavioral intervention, as long as the work directly aligns with NIAMS mission areas.
Does the trial need to be ready to enroll participants?
Yes. The FOA is aimed at studies that are implementation-ready, meaning they are prepared to begin enrolling participants and conducting the intervention.
Does NIAMS expect trials to be hypothesis-driven?
Yes. NIAMS signals it is looking for hypothesis-driven trials that are structured around clear, measurable milestones and positioned to make a meaningful impact in NIAMS-relevant clinical research.
What does "milestone-defined" mean in this context?
The FOA emphasizes milestone-defined trials. In practical terms, applicants are expected to propose concrete performance and timeline targets (for example, site activation, recruitment rates, retention targets, data quality indicators, and interim deliverables) and to be prepared for monitoring against those targets during the award period.
Is NIH involvement expected during the award?
Yes. Because this is a U01 cooperative agreement, substantial NIH involvement consistent with the cooperative agreement model is expected. While investigators run the trial, NIAMS program staff typically partner on coordination around agreed-upon milestones, progress oversight, and other collaborative activities intended to keep the trial on track.
Is an R34 planning grant required before applying for the U01?
NIAMS generally expects a two-part pathway: most applicants are expected to complete an R34 planning phase first (Part 1) and then apply for the U01 implementation award (Part 2). However, NIAMS allows flexibility for teams that can demonstrate they have already completed the necessary planning and preparation through other funding or established infrastructure.
What is the R34 planning phase typically used for?
The R34 is commonly used to complete essential pre-trial work such as finalizing the protocol and manual of operations, confirming feasibility and recruitment approaches, solidifying the statistical analysis plan, setting up data management and quality control systems, ensuring regulatory readiness (for example, IRB processes), and demonstrating that the trial is executable.
Can an applicant apply directly to the U01 without having an R34?
Yes. If a team has already completed all required planning and preparation through other credible means (such as other funding or established infrastructure), NIAMS indicates they may apply directly to the U01 without previously holding an R34.
What is the main thing NIAMS is looking for in U01 applications under this FOA?
The main emphasis is on implementation-ready, interventional clinical trials that align with NIAMS mission areas, are hypothesis-driven, and include clear, measurable milestones to guide execution and accountability.
Who is eligible to apply?
Eligibility is broad and includes many types of domestic organizations and governmental entities. Eligible applicants listed include:
- State, county, city or township, and special district governments
- Independent school districts
- Public and state-controlled institutions of higher education
- Private institutions of higher education
- Federally recognized Native American tribal governments
- Public housing authorities/Indian housing authorities
- Native American tribal organizations other than federally recognized tribal governments
- Nonprofits (501(c)(3) and non-501(c)(3); excluding higher education institutions when categorized separately)
- For-profit organizations other than small businesses
- Small businesses
Are there additional eligible applicant categories called out?
Yes. The FOA highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, tribal governments that are not federally recognized, and U.S. territories or possessions.
Are foreign (non-U.S.) organizations eligible to apply as the applicant?
No. Non-domestic (non-U.S.) entities (foreign institutions/organizations) are not eligible to apply as the applicant organization under this FOA.
Are non-domestic components of U.S. organizations eligible to apply?
No. The FOA states that non-domestic components of U.S. organizations are also not eligible to apply.
Are foreign components allowed at all?
Yes. While foreign institutions cannot be the applicant, the FOA indicates that foreign components (as defined in the NIH Grants Policy Statement) are allowed. This means a U.S. applicant organization may include certain foreign collaborations or performance sites if they meet NIH policy definitions and requirements.
What is the activity category and CFDA number for this opportunity?
The activity category is Health, and the CFDA number associated with this opportunity is 93.846.
What are the key dates provided in the record?
The FOA record provided lists a creation date of 2018-01-26 and an original closing date of 2020-11-03.
Does the provided information list an award ceiling or number of awards?
No. The provided source data does not specify an award ceiling or the expected number of awards.
Where would an applicant typically look for budget expectations or caps?
Because the record provided does not include an award ceiling, expected number of awards, or budget norms, applicants would typically consult the full FOA text and NIAMS guidance for budget expectations, project period norms, and any institute-specific caps or constraints.
Browse more opportunities from the same category: Health
Next opportunity: NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics (R33 Clinical Trial Required)
Previous opportunity: The NCI Transition Career Development Award (K22 Independent Clinical Trial Required)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 18 594
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 18 594) also looked into and applied for these:
| Funding Opportunity |
|---|
| Clincal Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) Apply for PAR 18 597 Funding Number: PAR 18 597 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) Apply for PAR 18 596 Funding Number: PAR 18 596 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Coordination Center for Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (U24 Clinical Trial Not Allowed) Apply for RFA HL 19 001 Funding Number: RFA HL 19 001 Agency: National Institutes of Health Category: Health Funding Amount: $320,000 |
| Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) (R25 Clinical Trial Not Allowed) Apply for RFA HL 19 002 Funding Number: RFA HL 19 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R41/R42 Clinical Trial Not Allowed) Apply for PAR 18 608 Funding Number: PAR 18 608 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Methods Development in Natural Products Chemistry (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 607 Funding Number: PA 18 607 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R43/R44 Clinical Trial Not Allowed) Apply for PA 18 610 Funding Number: PA 18 610 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Required) Apply for PA 18 613 Funding Number: PA 18 613 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials for Small Business (R44) - Clinical Trial Required Apply for PAR 18 618 Funding Number: PAR 18 618 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Exploratory Clinical Trials for Small Business (R42) - Clinical Trial Required Apply for PAR 18 617 Funding Number: PAR 18 617 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Transition Award for Intramural Fellows (K22 Clinical Trials Not Allowed) Apply for PA 18 614 Funding Number: PA 18 614 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development of Novel and Emerging Technologies for Cryogenic or Long-term Preservation and Revival of Drosophila and Zebrafish Genetic Stocks (R41/R42 Clinical Trial Not Allowed) Apply for PA 18 609 Funding Number: PA 18 609 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Disease Mechanisms of Prenatal and Pediatric Hydrocephalus (R01 Clinical Trial Not Allowed) Apply for PA 18 622 Funding Number: PA 18 622 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tools to Enhance the Study of Prenatal and Pediatric Hydrocephalus (R21 Clinical Trial Not Allowed) Apply for PA 18 623 Funding Number: PA 18 623 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Research to Support the Reduction and Elimination of Mental Health Disparities (Admin Supp Clinical Trial Optional) Apply for PA 18 621 Funding Number: PA 18 621 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R21 - Clinical Trial Optional) Apply for PA 18 620 Funding Number: PA 18 620 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Understanding Processes of Recovery in the Treatment of Alcohol Use Disorder (R01 - Clinical Trial Optional) Apply for PA 18 619 Funding Number: PA 18 619 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Dementia Care and Caregiver Support Interventions (R01 - Clinical Trial Required) Apply for RFA AG 18 030 Funding Number: RFA AG 18 030 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| NIBIB Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required) Apply for PA 18 631 Funding Number: PA 18 631 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Biobehavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01 Clinical Trial Optional) Apply for RFA MH 19 130 Funding Number: RFA MH 19 130 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 594", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.